Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

X4 Pharmaceuticals, Inc. buy Wells Fargo & Company

Start price
€0.17
11.07.26 / 50%
Target price
-
11.07.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 11.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.
Performance without dividends (%)
Name 1w 1m
X4 Pharmaceuticals, Inc. - -
iShares Core DAX® -1,06 % 5,01 %
iShares Nasdaq 100 -2,39 % 0,86 %
iShares Nikkei 225® -4,36 % 1,21 %
iShares S&P 500 -1,78 % 1,39 %

Comments by Wells_Fargo___Compan for this prediction

In the thread X4 Pharmaceuticals, Inc. diskutieren

X4 Pharmaceuticals (XFOR) was upgraded by Wells Fargo & Company to "strong-buy".
Ratings data for XFOR provided by MarketBeat

Stopped prediction by Wells_Fargo___Compan for X4 Pharmaceuticals, Inc.

buy
X4 Pharmaceuticals, Inc.

Start price
Target price
Perf. (%)
€0.17
10.07.26
€9.61
10.07.27
-
25.04.25